Maternal antibodies in breast milk protect the child from enterovirus infections

Karita Sadeharju1, Mikael Knip, Suvi M Virtanen

  • 1Department of Virology, University of Tampere and Tampere University Hospital, Tampere, Finland.

Pediatrics
|May 3, 2007
PubMed

Insights

Breastfeeding protects infants from enterovirus infections. Maternal antibodies in breast milk are key to this protective effect, reducing infection rates in infants who are breastfed for longer durations.

Area of Science:

  • Immunology
  • Pediatrics
  • Virology

Background:

  • Enterovirus infections pose significant risks to infants, potentially leading to severe health complications.
  • Understanding protective mechanisms against these common viral infections is crucial for infant health.

Purpose of the Study:

  • To investigate the protective role of breastfeeding against enterovirus infections in infants.
  • To determine if maternal antibodies in breast milk or infant circulation contribute to this protection.

Main Methods:

  • Prospective follow-up of 150 infants from birth, monitoring for enterovirus infections.
  • Collection of maternal breast milk and blood samples at 3-month intervals for antibody and RNA analysis.
  • Recording breastfeeding duration and analyzing maternal serum from pregnancy through postpartum.

Main Results:

  • Enterovirus infections occurred in 43% of infants by age one; 15% of mothers were infected during pregnancy.
  • Infants exclusively breastfed for over two weeks experienced fewer enterovirus infections compared to those breastfed for two weeks or less.
  • Elevated maternal antibody levels in serum and breast milk correlated with reduced infection frequency, specifically in infants breastfed longer than two weeks.

Conclusions:

  • Breastfeeding demonstrates a significant protective effect against enterovirus infections during infancy.
  • The primary mechanism for this protection appears to be the transfer of maternal antibodies present in breast milk.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...